153 related articles for article (PubMed ID: 3263418)
41. Vomitoxin-mediated IL-2, IL-4, and IL-5 superinduction in murine CD4+ T cells stimulated with phorbol ester calcium ionophore: relation to kinetics of proliferation.
Ouyang YL; Azcona-Olivera JI; Murtha J; Pestka JJ
Toxicol Appl Pharmacol; 1996 Jun; 138(2):324-34. PubMed ID: 8658534
[TBL] [Abstract][Full Text] [Related]
42. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
Jalava A; Akerman K; Heikkilä J
J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723
[TBL] [Abstract][Full Text] [Related]
43. Differential roles of the tandem C1 domains of protein kinase C delta in the biphasic down-regulation induced by bryostatin 1.
Lorenzo PS; Bögi K; Hughes KM; Beheshti M; Bhattacharyya D; Garfield SH; Pettit GR; Blumberg PM
Cancer Res; 1999 Dec; 59(24):6137-44. PubMed ID: 10626804
[TBL] [Abstract][Full Text] [Related]
44. Co-induction of lymphokine synthesis by the antineoplastic bryostatins.
Mohr H; Pettit GR; Plessing-Menze A
Immunobiology; 1987 Nov; 175(5):420-30. PubMed ID: 3123367
[TBL] [Abstract][Full Text] [Related]
45. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes.
Chin CS; Miller CH; Graham L; Parviz M; Zacur S; Patel B; Duong A; Bear HD
Int Immunol; 2004 Sep; 16(9):1283-94. PubMed ID: 15262898
[TBL] [Abstract][Full Text] [Related]
46. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.
Chen FL; Kung JT
J Immunol; 1996 Mar; 156(6):2036-44. PubMed ID: 8690890
[TBL] [Abstract][Full Text] [Related]
47. Costimulation of cAMP and protein kinase C pathways inhibits the CD3-dependent T cell activation and leads to a persistent expression of the AP-1 transcription factor.
Rincón M; Tugores A; de Landázuri MO; López-Botet M
Cell Immunol; 1993 Jul; 149(2):343-56. PubMed ID: 8392437
[TBL] [Abstract][Full Text] [Related]
48. Mechanisms of T cell activation by the calcium ionophore ionomycin.
Chatila T; Silverman L; Miller R; Geha R
J Immunol; 1989 Aug; 143(4):1283-9. PubMed ID: 2545785
[TBL] [Abstract][Full Text] [Related]
49. The catalytic domain of protein kinase Cdelta confers protection from down-regulation induced by bryostatin 1.
Lorenzo PS; Bögi K; Acs P; Pettit GR; Blumberg PM
J Biol Chem; 1997 Dec; 272(52):33338-43. PubMed ID: 9407126
[TBL] [Abstract][Full Text] [Related]
50. Synthetic bryostatin analogues activate the RasGRP1 signaling pathway.
Stone JC; Stang SL; Zheng Y; Dower NA; Brenner SE; Baryza JL; Wender PA
J Med Chem; 2004 Dec; 47(26):6638-44. PubMed ID: 15588099
[TBL] [Abstract][Full Text] [Related]
51. The effects of temperature and oleic acid on murine memory and virgin T cell activation: interleukin-2 secretion and interleukin-2 receptor expression.
Wooten RM; Clem LW; Bly JE
Cell Immunol; 1993 Nov; 152(1):35-48. PubMed ID: 8242770
[TBL] [Abstract][Full Text] [Related]
52. Bryostatin-1 and IFN-gamma synergize for the expression of the inducible nitric oxide synthase gene and for nitric oxide production in murine macrophages.
Taylor LS; Cox GW; Melillo G; Bosco MC; Espinoza-Delgado I
Cancer Res; 1997 Jun; 57(12):2468-73. PubMed ID: 9192827
[TBL] [Abstract][Full Text] [Related]
53. Bryostatin-1 and IL-2 synergize to induce IFN-gamma expression in human peripheral blood T cells: implications for cancer immunotherapy.
Curiel RE; Garcia CS; Farooq L; Aguero MF; Espinoza-Delgado I
J Immunol; 2001 Nov; 167(9):4828-37. PubMed ID: 11673486
[TBL] [Abstract][Full Text] [Related]
54. Signal requirement for interleukin-1-dependent interleukin 2 production by a human leukemia-derived HSB.2 subclone.
Mukaida N; Kasahara T; Yagisawa H; Shioiri-Nakano K; Kawai T
J Immunol; 1987 Nov; 139(10):3321-9. PubMed ID: 3500216
[TBL] [Abstract][Full Text] [Related]
55. Protein kinase C isotypes in human erythroleukemia cell proliferation and differentiation.
Hocevar BA; Morrow DM; Tykocinski ML; Fields AP
J Cell Sci; 1992 Mar; 101 ( Pt 3)():671-9. PubMed ID: 1522149
[TBL] [Abstract][Full Text] [Related]
56. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
[TBL] [Abstract][Full Text] [Related]
57. Nuclear factor-kappa B in signal conduction of protein kinase C in T lymphocytes from an asthmatic guinea pig model.
Xiong W; Xu Y; Zhang Z; Wang X; Mo B; Fu J
Chin Med J (Engl); 2002 May; 115(5):685-9. PubMed ID: 12133535
[TBL] [Abstract][Full Text] [Related]
58. Different biological effects of the two protein kinase C activators bryostatin-1 and TPA on human carcinoma cell lines.
Steube KG; Grunicke D; Drexler HG
Invest New Drugs; 1994; 12(1):15-23. PubMed ID: 7960600
[TBL] [Abstract][Full Text] [Related]
59. Studies on immunomodulatory properties of isoniazid. IV. Effect of isoniazid on T lymphocyte activation by phorbol ester tumor promoter.
Kucharz EJ; Sierakowski SJ
J Hyg Epidemiol Microbiol Immunol; 1990; 34(4):381-5. PubMed ID: 2100752
[TBL] [Abstract][Full Text] [Related]
60. Functional properties of intra-epithelial lymphocytes from mouse small intestine. IV. Investigation of the proliferative capacity of IEL using phorbol ester and calcium ionophore.
Mowat AM; McInnes IB; Parrott DM
Immunology; 1989 Mar; 66(3):398-403. PubMed ID: 2495248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
